Cai L - Search Results

1

Telodendrimer nanocarrier for co-delivery of paclitaxel and cisplatin: A synergistic combination nanotherapy for ovarian cancer treatment.

Cai L, Xu G, Shi C, Guo D, Wang X, Luo J. Cai L, et al. Biomaterials. 2015 Jan;37:456-468. doi: 10.1016/j.biomaterials.2014.10.044. Epub 2014 Oct 31. Biomaterials. 2015. PMID: 25453973 Free PMC article.

2

Gene therapy of adenovirus mediated CD ::upp/5-FC directed by GSTP1 promoter in cisplatin-resistant ovarian cancer.

Wang Z, Cai L, Wang H. Wang Z, et al. Among authors: cai l. Gynecol Oncol. 2005 Mar;96(3):643-50. doi: 10.1016/j.ygyno.2004.09.066. Gynecol Oncol. 2005. PMID: 15721406

3

Gene therapy for ovarian cancer using adenovirus-mediated transfer of cytosine deaminase gene and uracil phosphoribosyltransferase gene directed by MDR1 promoter.

Lu S, Wang X, Xiao L, Cai L, Zhang Y, Wang H, Wang Z. Lu S, et al. Among authors: cai l. Cancer Biol Ther. 2007 Mar;6(3):397-404. doi: 10.4161/cbt.6.3.3754. Epub 2007 Mar 28. Cancer Biol Ther. 2007. PMID: 17471022 Free article.

4

Depletion of Dicer promotes epithelial ovarian cancer progression by elevating PDIA3 expression.

Zhu Y, Cai L, Guo J, Chen N, Yi X, Zhao Y, Cai J, Wang Z. Zhu Y, et al. Among authors: cai j, cai l. Tumour Biol. 2016 Oct;37(10):14009-14023. doi: 10.1007/s13277-016-5218-4. Epub 2016 Aug 5. Tumour Biol. 2016. PMID: 27492604

5

[Killing effect of adenovirus mediated fusion gene cytosine and deaminase uracil phosphoribosyl transferase directed by glutathione S-transferase P1 promoter on cisplatin-resistant ovarian cancer cells in vitro].

Cai LQ, Li M, Lu S, Wang HB, Wang ZH. Cai LQ, et al. Zhonghua Fu Chan Ke Za Zhi. 2004 Jul;39(7):478-81. Zhonghua Fu Chan Ke Za Zhi. 2004. PMID: 15347473 Chinese.

6

[Study of bcl-2 antisense oligodeoxynucleotides on reversal of cisplatin resistance in ovarian cancer cell line A2780/DDP].

Li M, Yu LL, Cai LQ, Wang HB, Wang ZH, Wang ZH. Li M, et al. Zhonghua Fu Chan Ke Za Zhi. 2006 Feb;41(2):121-5. Zhonghua Fu Chan Ke Za Zhi. 2006. PMID: 16640863 Chinese.

7

Interference with endogenous EZH2 reverses the chemotherapy drug resistance in cervical cancer cells partly by up-regulating Dicer expression.

Cai L, Wang Z, Liu D. Cai L, et al. Tumour Biol. 2016 May;37(5):6359-69. doi: 10.1007/s13277-015-4416-9. Epub 2015 Dec 2. Tumour Biol. 2016. PMID: 26631032

8

Let-7e sensitizes epithelial ovarian cancer to cisplatin through repressing DNA double strand break repair.

Xiao M, Cai J, Cai L, Jia J, Xie L, Zhu Y, Huang B, Jin D, Wang Z. Xiao M, et al. Among authors: cai j, cai l. J Ovarian Res. 2017 Apr 4;10(1):24. doi: 10.1186/s13048-017-0321-8. J Ovarian Res. 2017. PMID: 28376831 Free PMC article.

9

Fertility sparing surgery vs radical surgery for epithelial ovarian cancer: a meta-analysis of overall survival and disease-free survival.

Liu D, Cai J, Gao A, Wang Z, Cai L. Liu D, et al. Among authors: cai j, cai l. BMC Cancer. 2020 Apr 15;20(1):320. doi: 10.1186/s12885-020-06828-y. BMC Cancer. 2020. PMID: 32293358 Free PMC article.

10

Identification and validation of pyroptosis-related gene landscape in prognosis and immunotherapy of ovarian cancer.

Gao L, Ying F, Cai J, Peng M, Xiao M, Sun S, Zeng Y, Xiong Z, Cai L, Gao R, Wang Z. Gao L, et al. Among authors: cai j, cai l. J Ovarian Res. 2023 Jan 27;16(1):27. doi: 10.1186/s13048-022-01065-2. J Ovarian Res. 2023. PMID: 36707884 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,205 results

Search Page

Filters